FDA Approves Cellcept (mycophenolate mofetil) for Organ Rejection Prophylaxis
FDA approves Cellcept to prevent organ rejection in transplant patients.
The FDA approved Cellcept (mycophenolate mofetil) for prophylaxis of organ rejection in adult and pediatric recipients 3 months and older of…
The FDA has approved Cellcept (mycophenolate mofetil) to help prevent organ rejection in patients who have received a kidney, heart, or live…
FDA Approves Myhibbin (mycophenolate mofetil) for Organ Rejection Prophylaxis
FDA approves new liquid and capsule form of transplant rejection drug
The FDA approved Myhibbin (mycophenolate mofetil) for prophylaxis of organ rejection in adult and pediatric recipients 3 months and older of…
The FDA approved Myhibbin, a new form of mycophenolate mofetil, to prevent organ rejection in kidney, heart, and liver transplant patients a…
Chemo combinations with ivonescimab, sacituzumab tirumotecan, and amivantamab show significant progression-free survival benefits
New Treatment Combinations Show Promise for Advanced Lung Cancer
This systematic review and meta-analysis of 3,606 patients evaluated 8 treatment strategies for advanced EGFR-mutant NSCLC. The analysis fou…
Specific drug combinations, including ivonescimab and amivantamab, show potential benefits for patients with advanced EGFR-mutant lung cance…
Triple consolidation with CAR T cells yields sustained remission in relapsed BPDCN
New treatment strategy shows promise for rare blood cancer
This case report and literature review describes a 55-year-old man with relapsed/refractory BPDCN and CNS involvement who achieved sustained…
A new three-part treatment plan helped a man with a rare, aggressive blood cancer achieve long-term remission when no donor was available.
Bortezomib, cyclophosphamide, and dexamethasone achieved remission in a patient with AL amyloidosis and POEMS syndrome
Treatment shows success for heart failure and rare blood diseases
This case report and literature review describes the treatment of an elderly male with concurrent AL amyloidosis and POEMS syndrome. The pat…
A new look at a complex case reveals how a specific drug combination helped an elderly man with multiple rare conditions.
Combination Immunotherapy Improves Outcomes for BCG Unresponsive Non Muscle Invasive Bladder Cancer
Combination immunotherapy shows promise for bladder cancer patients
Multi-agent immunotherapy regimens show superior response rates and progression-free survival compared to monotherapy in patients with NMIBC…
A new combination of immunotherapies may improve response rates and survival for patients with specific types of bladder cancer.
Financial toxicity and food insecurity create a health-economic pathway impacting nutrition in women with cancer
Financial stress and food insecurity impact health for women with cancer
This mini review explores the link between financial toxicity, food insecurity, and nutritional vulnerability in women with cancer. The auth…
High medical costs and lack of reliable food sources can lead to malnutrition and fatigue in women fighting breast and gynecologic cancers.
Lower baseline soluble PD-L1 levels correlate with improved progression-free and overall survival in NSCLC
Blood Marker May Predict Lung Cancer Outcomes
This meta-analysis of 1967 patients with non-small cell lung cancer (NSCLC) found that lower baseline sPD-L1 levels are associated with sign…
A protein in the blood called sPD-L1 may help predict how well lung cancer patients respond to treatment.
TKI plus chemotherapy achieves deep molecular remission in Ph+ leukemia case with diagnostic framework
One patient's leukemia remission offers clues for rare diagnosis
This systematic review with a case report describes a patient with Philadelphia chromosome-positive leukemia who achieved complete remission…
A patient with a rare leukemia achieved deep remission for 35 months. The case highlights how to tell apart two similar-looking blood cancer…
Calcium homeostasis dysregulation serves as an integrative regulatory node in allergic rhinitis inflammation
Calcium Imbalance May Drive Inflammation in Allergic Rhinitis
This systematic review explores the role of calcium signaling in allergic rhinitis pathogenesis, including mucosal barrier maintenance and i…
New research suggests that how your body manages calcium levels may play a key role in maintaining nasal barriers and driving allergic rhini…
Immunonutrition may improve management of radiation-induced oral mucositis in head and neck cancer patients
Immunonutrition may help manage mouth sores in head and neck cancer
This narrative review examines the role of immunonutrition for managing oral mucositis in patients with head and neck malignancies undergoin…
Patients with head and neck cancer often suffer from painful mouth sores. New evidence suggests immunonutrition could help manage these symp…
Metabolic checkpoints like lactate and adenosine drive immune escape and resistance to checkpoint blockade
Metabolic Checkpoints May Impact Immune Therapy for Cancer
This mini review synthesizes the role of metabolic immune checkpoints, including lactate, adenosine, tryptophan-derived metabolites, and nuc…
Specific metabolic markers like lactate and adenosine may influence how well immune checkpoint treatments work against cancer cells.